
Validea's guru fundamental report indicates that Gilead Sciences (GILD) receives a 100% rating based on their Twin Momentum Investor model, which is based on the published strategy of Dashan Huang. The model combines fundamental momentum, using seven fundamental variables, with price momentum and has historically identified stocks that outperform the market. The rating suggests strong interest in GILD based on the firm’s underlying fundamentals and valuation.
Gilead Sciences Inc. (GILD) has received a perfect 100% rating from Validea's Twin Momentum Investor model, a strategy developed by Dashan Huang that combines fundamental momentum and price momentum. This top-tier score signifies strong interest in GILD, reflecting positively on the firm's underlying fundamentals and its current valuation. The model, which has historically identified stocks capable of market outperformance, specifically confirmed GILD's strength by passing criteria for 'FUNDAMENTAL MOMENTUM', 'TWELVE MINUS ONE MOMENTUM', and the 'FINAL RANK'. The fundamental momentum component is derived from a composite of seven key financial variables, including earnings, return on equity, return on assets, accrual operating profitability to equity, cash operating profitability to assets, gross profit to assets, and net payout ratio, indicating a broad-based improvement in the company's financial health. This assessment is further supported by a 'strongly positive' sentiment score of 0.85 specifically for GILD, underscoring the bullish implications of this multifaceted analysis for the large-cap biotechnology company.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment